ISOLATED MYELOSARCOMA TREATED AS AML, WITH PROGRESSION TO MDS/MPN

被引：0
|
作者：
Fuentes, A. [1 ]
LaBier, G. [2 ]
Boulmay, B. [1 ]
机构：
[1] LSU Hlth Sci Ctr, Metairie, LA USA
[2] LSU, New Orleans, LA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2018年 / 66卷 / 02期
关键词：
D O I：
10.1136/jim-2017-000697.217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
217
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [41] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Talati, Chetasi
    Padron, Eric
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 425 - 433
  • [42] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Chetasi Talati
    Eric Padron
    Current Hematologic Malignancy Reports, 2016, 11 : 425 - 433
  • [43] A RETROSPECTIVE VALIDATION OF INTERNATIONAL CONSORTIUM FOR MDS/MPN RESPONSE CRITERIA IN CMML TREATED WITH HYPOMETHYLATING AGENTS
    Duchmann, M.
    Braun, T.
    Micol, J. B.
    Platzbecker, U.
    Park, S.
    Pilorge, S.
    Beyne-Rauzy, O.
    Vey, N.
    Sebert, M.
    Gruson, B.
    Dumas, P. Y.
    Guieze, R.
    Chretien, M. L.
    Laribi, K.
    Chait, Y.
    Legros, L.
    Hirsch, P.
    Solary, E.
    Fenaux, P.
    Itzykson, R.
    LEUKEMIA RESEARCH, 2017, 55 : S30 - S31
  • [44] Multilineage Dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: A comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)
    Haferlach, T.
    Miesner, M.
    Bacher, U.
    Weiss, T.
    Macijewski, K.
    Kohlmann, A.
    Klein, H-U
    Dugas, M.
    Kern, W.
    Schnittger, S.
    Haferlach, C.
    ONKOLOGIE, 2010, 33 : 8 - 8
  • [45] Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC)
    Miesner, Miriam
    Haferlach, Claudia
    Bacher, Ulrike
    Weiss, Tamara
    Macijewski, Katja
    Kohlmann, Alexander
    Klein, Hans-Ulrich
    Dugas, Martin
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2010, 116 (15) : 2742 - 2751
  • [46] A Clinicopathologic Study of RUNX1 Mutated MDS and MDS/MPN
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Gao, Juehua
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1251 - 1251
  • [47] TREATMENT OF PROGRESSION OF MYELOPROLIFERATIVE NEOPLASM TO MDS/AML BY AZACYTIDINE: A REPORT ON 44 PATIENTS
    Thepot, S.
    Itzykson, R.
    Raffoux, E.
    Recher, C.
    Quesnel, B.
    Dreyfus, F.
    Cluzeau, T.
    Chait, Y.
    Harel, S.
    Delauney, J.
    Schlaifer, D.
    Thyss, A.
    Salanoubat, C.
    Dartigeas, C.
    Stamatoulas, A.
    Koka, A. Marfaing
    Dumontet, C.
    Cassinat, B.
    Zerhouni, C.
    Roussel, M.
    Kiladjian, J. J.
    Gardin, C.
    Fenaux, P.
    Ades, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 438 - 439
  • [48] TRANSCRIPTIONAL DYSREGULATION IN PRE-LEUKEMIC STEM AND PROGENITORS AND THEIR PROGRESSION TO MDS AND AML
    Steidl, Ulrich G.
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S34 - S34
  • [49] Iron overload and haematopoiesis in MDS: Does blood transfusion promote progression to AML?
    Chan, L.
    Buckstein, R.
    Reis, M.
    Chesney, A.
    Lam, A.
    Cheung, M.
    Piliotis, E.
    Gu, L.
    Wells, R.
    LEUKEMIA RESEARCH, 2009, 33 : S112 - S113
  • [50] Rapid progression from MDS to AML with gastric submucosal tumour as an extramedullary infiltration
    Kobayashi, Keigo
    Umekawa, Yasuhiro
    BMJ CASE REPORTS, 2024, 17 (04)
12345